"SARS-CoV-2" の関連情報検索結果

Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections ...



Central role of glycosylation processes in human genetic susceptibility to SARS-CoV-2 infections with Omicron variants  Nature

Scientists say these two viruses may become the next public health threats - UF Health



Scientists say these two viruses may become the next public health threats  UF Health

Annual COVID-19 Burden Remains Substantial in the US - Infectious Disease Advisor



Annual COVID-19 Burden Remains Substantial in the US  Infectious Disease Advisor

SARS-CoV-2 Fragments Attack Key Immune Cells, Explaining Severe COVID - Technology Networks



SARS-CoV-2 Fragments Attack Key Immune Cells, Explaining Severe COVID  Technology Networks

Surveillance and Data Analytics | COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)



Surveillance and Data Analytics | COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

Wastewater surveillance reveals hidden COVID spread beyond reported cases - News-Medical



Wastewater surveillance reveals hidden COVID spread beyond reported cases  News-Medical

SARS-CoV-2-derived RNA replicons as safe and effective vaccines - PNAS



SARS-CoV-2-derived RNA replicons as safe and effective vaccines  PNAS

Weekly respiratory virus update, week 4, January 2026 - ECDC



Weekly respiratory virus update, week 4, January 2026  ECDC

Assessing SARS-CoV-2 Virus Levels in Sewage - U.S. Environmental Protection Agency (.gov)



Assessing SARS-CoV-2 Virus Levels in Sewage  U.S. Environmental Protection Agency (.gov)

Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron e...



Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR): a retrospective cohort study  The Lancet

COVID exposure in utero not linked to early neurodevelopmental issues, study suggests - CIDRAP



COVID exposure in utero not linked to early neurodevelopmental issues, study suggests  CIDRAP

SARS-CoV-2 variants: biology, pathogenicity, immunity and control - Nature



SARS-CoV-2 variants: biology, pathogenicity, immunity and control  Nature

Molecular basis of SARS-CoV-2 proofreading enzyme–mediated resistance to remdesivir - PNAS



Molecular basis of SARS-CoV-2 proofreading enzyme–mediated resistance to remdesivir  PNAS

Presence of SARS-CoV-2 in fetal organs via intraamniotic infection - Nature



Presence of SARS-CoV-2 in fetal organs via intraamniotic infection  Nature

Tracing SARS-CoV-2 clusters across local scales using genomic data - PNAS



Tracing SARS-CoV-2 clusters across local scales using genomic data  PNAS

SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature



SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade  Nature

Paternal SARS-CoV-2 infection impacts sperm small noncoding RNAs and increases anxiety in offspri...



Paternal SARS-CoV-2 infection impacts sperm small noncoding RNAs and increases anxiety in offspring in a sex-dependent manner  Nature

Aggregation potency and proinflammatory effects of SARS-CoV-2 proteins | Scientific Reports - Nature



Aggregation potency and proinflammatory effects of SARS-CoV-2 proteins | Scientific Reports  Nature

Prolonged immune activation in post-acute sequelae of SARS-CoV-2: neutrophil dynamics and therape...



Prolonged immune activation in post-acute sequelae of SARS-CoV-2: neutrophil dynamics and therapeutic insights  Nature

SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses - PNAS



SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses  PNAS

SARS-CoV-2 nucleocapsid protein directly prevents cGAS–DNA recognition through competitive bindin...



SARS-CoV-2 nucleocapsid protein directly prevents cGAS–DNA recognition through competitive binding  PNAS

Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of work...



Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of workdays in healthcare workers | Communications Medicine  Nature

SARS-CoV-2 infection induces pro-fibrotic and pro-thrombotic foam cell formation - Nature



SARS-CoV-2 infection induces pro-fibrotic and pro-thrombotic foam cell formation  Nature

Metformin shown to prevent long COVID across risk groups in multiple randomized trials - Medical ...



Metformin shown to prevent long COVID across risk groups in multiple randomized trials  Medical Xpress

Inhibition of CXCL10 and IFN-γ ameliorates myocarditis in preclinical models of SARS-CoV-2 mRNA v...



Inhibition of CXCL10 and IFN-γ ameliorates myocarditis in preclinical models of SARS-CoV-2 mRNA vaccination  Science | AAAS

SARS-CoV-2 Causes Buildup of Alzheimer’s-Related Peptides in the Retina - Yale School of Medicine



SARS-CoV-2 Causes Buildup of Alzheimer’s-Related Peptides in the Retina  Yale School of Medicine

COVID-19 Treatment Clinical Care for Outpatients - Centers for Disease Control and Prevention | C...



COVID-19 Treatment Clinical Care for Outpatients  Centers for Disease Control and Prevention | CDC (.gov)

New coronavirus subspecies with SARS-CoV-2–like mutation discovered in Brazilian bat - CIDRAP



New coronavirus subspecies with SARS-CoV-2–like mutation discovered in Brazilian bat  CIDRAP

SARS-CoV-2 origins: imperfect but clear evidence - The Lancet



SARS-CoV-2 origins: imperfect but clear evidence  The Lancet

COVID-19 and Breastfeeding - Centers for Disease Control and Prevention | CDC (.gov)



COVID-19 and Breastfeeding  Centers for Disease Control and Prevention | CDC (.gov)

Solving Long COVID: How decades of HIV research paved the way - Lake County News,California



Solving Long COVID: How decades of HIV research paved the way  Lake County News,California

COVID-19 | Yellow Book - Centers for Disease Control and Prevention | CDC (.gov)



COVID-19 | Yellow Book  Centers for Disease Control and Prevention | CDC (.gov)

Could this Molecule be ‘Checkmate’ for Coronaviruses like SARS-CoV-2? - UC San Francisco



Could this Molecule be ‘Checkmate’ for Coronaviruses like SARS-CoV-2?  UC San Francisco

Weekly respiratory virus update, week 3, January 2026 - ECDC



Weekly respiratory virus update, week 3, January 2026  ECDC

Types of COVID-19 Treatment - Centers for Disease Control and Prevention | CDC (.gov)



Types of COVID-19 Treatment  Centers for Disease Control and Prevention | CDC (.gov)

National COVID-19 trends, January 27 - The Sick Times



National COVID-19 trends, January 27  The Sick Times

Wastewater surveillance reveals true scale of COVID-19 spread as clinical testing declines - Asia...



Wastewater surveillance reveals true scale of COVID-19 spread as clinical testing declines  Asia Research News |

WHO Scientific advisory group issues report on origins of COVID-19 - World Health Organization (WHO)



WHO Scientific advisory group issues report on origins of COVID-19  World Health Organization (WHO)

How does long COVID develop? New piece of the puzzle found - Medical Xpress



How does long COVID develop? New piece of the puzzle found  Medical Xpress

Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Bination...



Burden of Cardiovascular Outcomes After SARS-CoV-2 Infection in South Korea and Japan: A Binational Population-Based Cohort Study | Circulation  American Heart Association Journals

SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Tar...



SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family  PR Newswire

Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Pa...



Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Path to Severe COVID  Johns Hopkins Medicine

Long COVID Linked to New-Onset Allergies - Medscape



Long COVID Linked to New-Onset Allergies  Medscape

SARS-CoV-2 spike protein: structure, viral entry and variants - Nature



SARS-CoV-2 spike protein: structure, viral entry and variants  Nature

Statement on the antigen composition of COVID-19 vaccines - World Health Organization (WHO)



Statement on the antigen composition of COVID-19 vaccines  World Health Organization (WHO)

AI-designed pandemic is not science fiction - AFR



AI-designed pandemic is not science fiction  AFR

Structural basis of SARS-CoV-2 polymerase inhibition by nonnucleoside inhibitor HeE1-2Tyr - PNAS



Structural basis of SARS-CoV-2 polymerase inhibition by nonnucleoside inhibitor HeE1-2Tyr  PNAS

SARS-CoV-2 Vaccines and Multiple Sclerosis - Neurology® Journals



SARS-CoV-2 Vaccines and Multiple Sclerosis  Neurology® Journals

How to Protect Yourself and Others | COVID-19 - Centers for Disease Control and Prevention | CDC ...



How to Protect Yourself and Others | COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

Some still tout ivermectin as a cure-all. Here’s what the science says - Straight Arrow News - SAN



Some still tout ivermectin as a cure-all. Here’s what the science says  Straight Arrow News - SAN

A calibration of nucleic acid (PCR) by antibody (IgG) tests in Germany: the course of SARS-CoV-2 ...



A calibration of nucleic acid (PCR) by antibody (IgG) tests in Germany: the course of SARS-CoV-2 infections estimated  Frontiers

SK Bioscience Launches Global Trial For Universal Coronavirus Vaccine - Evrim Ağacı



SK Bioscience Launches Global Trial For Universal Coronavirus Vaccine  Evrim Ağacı

Lab Leak: The True Origins of Covid-19 - The White House (.gov)



Lab Leak: The True Origins of Covid-19  The White House (.gov)

The Virus Fragments That Hunt Their Prey by Shape - ScienceBlog.com



The Virus Fragments That Hunt Their Prey by Shape  ScienceBlog.com

National flu and COVID-19 surveillance report: 22 January 2026 (week 4) - GOV.UK



National flu and COVID-19 surveillance report: 22 January 2026 (week 4)  GOV.UK

SK Bioscience Initiates Phase 1/2 Clinical Trial of Vaccine Candidate Targeting Sarbecovirus Fami...



SK Bioscience Initiates Phase 1/2 Clinical Trial of Vaccine Candidate Targeting Sarbecovirus Family  Businesskorea

Targeting the SARS-CoV-2 reservoir in long COVID - The Lancet



Targeting the SARS-CoV-2 reservoir in long COVID  The Lancet

SK bioscience Begins Global Phase 1/2 Trial of Universal Coronavirus Vaccine Candidate - Korea IT...



SK bioscience Begins Global Phase 1/2 Trial of Universal Coronavirus Vaccine Candidate  Korea IT Times

Personalized mRNA Vaccine Reduces Melanoma Relapse at 5 Years - Cancer Health



Personalized mRNA Vaccine Reduces Melanoma Relapse at 5 Years  Cancer Health

Characteristics of SARS-CoV-2 and COVID-19 - Nature



Characteristics of SARS-CoV-2 and COVID-19  Nature

Tracking SARS-CoV-2 variants - World Health Organization (WHO)



Tracking SARS-CoV-2 variants  World Health Organization (WHO)

An assessment of the ongoing toll of the COVID-19 pandemic - World Socialist Web Site



An assessment of the ongoing toll of the COVID-19 pandemic  World Socialist Web Site

Coronavirus Disease 2019 (COVID-19) - Centers for Disease Control and Prevention | CDC (.gov)



Coronavirus Disease 2019 (COVID-19)  Centers for Disease Control and Prevention | CDC (.gov)

The proximal origin of SARS-CoV-2 - Nature



The proximal origin of SARS-CoV-2  Nature

The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and nam...



The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and naming it SARS-CoV-2  Nature

Transmission of SARS-CoV-2: implications for infection prevention precautions - World Health Orga...



Transmission of SARS-CoV-2: implications for infection prevention precautions  World Health Organization (WHO)

SARS-CoV-2 infection and persistence in the human body and brain at autopsy - Nature



SARS-CoV-2 infection and persistence in the human body and brain at autopsy  Nature

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras - The New En...



Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras  The New England Journal of Medicine

SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels - ...



SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels  Nature

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern - World Health Organization ...



Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern  World Health Organization (WHO)

SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) - Nature



SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)  Nature

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics - Nature



Human SARS-CoV-2 challenge uncovers local and systemic response dynamics  Nature

Acute and postacute sequelae associated with SARS-CoV-2 reinfection - Nature



Acute and postacute sequelae associated with SARS-CoV-2 reinfection  Nature

Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis - PNAS



Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis  PNAS

Reducing transmission of SARS-CoV-2 - Science | AAAS



Reducing transmission of SARS-CoV-2  Science | AAAS

SARS-CoV-2 spreads through cell-to-cell transmission - PNAS



SARS-CoV-2 spreads through cell-to-cell transmission  PNAS

Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024 -...



Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024  World Health Organization (WHO)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 - The New England Journal...



Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1  The New England Journal of Medicine

WHO-convened global study of origins of SARS-CoV-2: China Part - World Health Organization (WHO)



WHO-convened global study of origins of SARS-CoV-2: China Part  World Health Organization (WHO)

Long COVID after breakthrough SARS-CoV-2 infection - Nature



Long COVID after breakthrough SARS-CoV-2 infection  Nature

About COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)



About COVID-19  Centers for Disease Control and Prevention | CDC (.gov)

Effect of Vaccination on Household Transmission of SARS-CoV-2 in England - The New England Journa...



Effect of Vaccination on Household Transmission of SARS-CoV-2 in England  The New England Journal of Medicine

The evolution of SARS-CoV-2 - Nature



The evolution of SARS-CoV-2  Nature

SARS-CoV-2 evolution during treatment of chronic infection - Nature



SARS-CoV-2 evolution during treatment of chronic infection  Nature

How Prenatal Viral Infections Shape Immunity - Bioengineer.org



How Prenatal Viral Infections Shape Immunity  Bioengineer.org

A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection - Nature



A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection  Nature

How lung distress from SARS-CoV-2 can cause heart damage - National Institutes of Health (NIH) | ...



How lung distress from SARS-CoV-2 can cause heart damage  National Institutes of Health (NIH) | (.gov)

Identification of SARS-CoV-2 inhibitors using lung and colonic organoids - Nature



Identification of SARS-CoV-2 inhibitors using lung and colonic organoids  Nature

SARS-CoV-2 variants, spike mutations and immune escape - Nature



SARS-CoV-2 variants, spike mutations and immune escape  Nature

SARS-CoV-2 Infection in Children - The New England Journal of Medicine



SARS-CoV-2 Infection in Children  The New England Journal of Medicine

SARS-CoV-2 fragments may cause problems after infection - National Institutes of Health (NIH) | (...



SARS-CoV-2 fragments may cause problems after infection  National Institutes of Health (NIH) | (.gov)

Multiorgan and Renal Tropism of SARS-CoV-2 - The New England Journal of Medicine



Multiorgan and Renal Tropism of SARS-CoV-2  The New England Journal of Medicine

The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 - Science | AAAS



The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2  Science | AAAS

Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge ...



Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge  Nature

Joint statement on the prioritization of monitoring SARS-CoV-2 infection in wildlife and preventi...



Joint statement on the prioritization of monitoring SARS-CoV-2 infection in wildlife and preventing the formation of animal reservoirs  World Health Organization (WHO)

SARS-CoV-2 Variants and Vaccines - The New England Journal of Medicine



SARS-CoV-2 Variants and Vaccines  The New England Journal of Medicine

SARS-CoV-2 pathogenesis - Nature



SARS-CoV-2 pathogenesis  Nature

SARS-CoV-2 infection in free-ranging white-tailed deer - Nature



SARS-CoV-2 infection in free-ranging white-tailed deer  Nature

SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells - N...



SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells  Nature

SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus virginianus) - PNAS



SARS-CoV-2 exposure in wild white-tailed deer (Odocoileus virginianus)  PNAS